Daibao Machinery STC Tube Centrifuge: An Efficient Separation Solution for the Biopharmaceutical Industry

In biopharmaceutical manufacturing, achieving efficient and sterile separation has long been a critical challenge. Conventional centrifuges are often complex to operate and struggle to meet stringent GMP standards. Daibao Machinery’s STC series of fully automatic tubular centrifuges is redefining separation processes with its advanced automation and exceptional performance.

Designed for key applications such as cell harvest, fermentation broth clarification, and biotherapeutic purification, the STC series features a high-capacity rotor (φ140mm × 760mm), reaching speeds up to 14,000 rpm and a separation factor of 15,366 ×g—ensuring reliable handling of demanding separations.

Its standout innovation lies in full-process automation: “one-button start/stop” enables unattended operation. Intelligent sensors continuously monitor speed, vibration, and temperature, supporting remote diagnostics and predictive maintenance—enhancing process consistency and reducing manual intervention.

Built for GMP compliance, the STC offers a fully enclosed fluid path. All wetted parts are crafted from 316L stainless steel, duplex stainless steel (2205), or Ti-6Al-4V titanium alloy, ensuring corrosion resistance and cleanliness. Integrated CIP (Clean-in-Place) and SIP (Sterilize-in-Place) eliminate disassembly-related contamination risks. Its low-shear inlet and central outlet design preserve biomolecule integrity, with clinical data showing >95% cell viability—significantly above industry averages.

The system features a user-friendly touchscreen interface with recipe management, audit trails, and electronic records compliant with FDA 21 CFR Part 11. Open communication protocols allow seamless integration with MES for real-time data analytics.

In practice, the STC delivers remarkable efficiency: a single unit can process up to 480 L/h of fermentation broth—over 30% faster than conventional models. A leading Chinese biopharma company reported a 40% increase in monoclonal antibody separation efficiency and a 25% reduction in labor costs after adoption.

With over a decade of expertise in centrifugal separation and trusted by 200+ biopharma clients worldwide, Daibao Machinery continues to set new benchmarks. The STC series not only meets today’s bioprocessing demands but also provides a scalable platform for future smart manufacturing.